Gossamer Bio Announces First Quarter 2025 Financial Results and Provides Business Update, Including Closure of New Patient Screening in Phase 3 PROSERA Study

Stock Information for Gossamer Bio Inc.

Loading

Please wait while we load your information from QuoteMedia.